| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |